Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$72.15
+1.5%
$66.49
$55.30
$94.99
$3.41B0.36678,855 shs452,059 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$128.07
+0.3%
$134.70
$111.97
$196.26
$3.14B0.88271,888 shs134,916 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$92.32
+0.4%
$94.51
$82.04
$111.45
$5.44B0.66534,902 shs537,281 shs
Neogen Corporation stock logo
NEOG
Neogen
$4.77
-3.4%
$5.56
$3.87
$18.58
$1.07B1.843.29 million shs7.01 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
+1.34%+3.09%+9.15%+13.82%-15.31%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+0.26%-3.88%-0.71%-14.55%+10.31%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+0.37%-1.55%-3.21%-11.86%+12.30%
Neogen Corporation stock logo
NEOG
Neogen
-3.44%-15.43%-21.29%-43.55%-71.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Haemonetics Corporation stock logo
HAE
Haemonetics
4.4568 of 5 stars
3.41.00.04.32.71.72.5
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.5468 of 5 stars
3.53.00.03.92.22.51.9
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
4.1339 of 5 stars
3.51.00.03.82.32.51.3
Neogen Corporation stock logo
NEOG
Neogen
3.687 of 5 stars
3.33.00.00.01.83.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Haemonetics Corporation stock logo
HAE
Haemonetics
2.78
Moderate Buy$97.8935.67% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$192.6750.44% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.00
Buy$109.1118.19% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.50
Moderate Buy$9.0088.68% Upside

Current Analyst Ratings Breakdown

Latest NEOG, MMSI, ICUI, and HAE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$106.00 ➝ $110.00
5/21/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$108.00 ➝ $112.00
5/21/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$106.00 ➝ $108.00
5/20/2025
Haemonetics Corporation stock logo
HAE
Haemonetics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$100.00 ➝ $100.00
5/15/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$100.00 ➝ $108.00
5/9/2025
Haemonetics Corporation stock logo
HAE
Haemonetics
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy$115.00 ➝ $105.00
5/9/2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetStrong-Buy ➝ Strong-Buy$197.00 ➝ $187.00
5/8/2025
Haemonetics Corporation stock logo
HAE
Haemonetics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$104.00 ➝ $84.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$106.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$127.00 ➝ $108.00
4/25/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$116.00 ➝ $108.00
(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.36B2.55$7.32 per share9.86$16.34 per share4.42
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.38B1.32$14.06 per share9.11$80.26 per share1.60
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.36B4.02$5.63 per share16.41$23.67 per share3.90
Neogen Corporation stock logo
NEOG
Neogen
$906.00M1.14$0.99 per share4.82$14.52 per share0.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Haemonetics Corporation stock logo
HAE
Haemonetics
$167.68M$3.3121.8014.321.1512.32%26.37%9.22%8/14/2025 (Estimated)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$117.69M-$3.83N/A23.54N/A-3.87%6.75%3.20%8/6/2025 (Estimated)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$120.36M$2.0445.2624.623.038.81%15.52%8.72%7/30/2025 (Estimated)
Neogen Corporation stock logo
NEOG
Neogen
-$9.42M-$2.23N/A9.73N/A-53.56%2.69%1.82%7/29/2025 (Estimated)

Latest NEOG, MMSI, ICUI, and HAE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.22$1.24+$0.02$1.17$329.38 million$330.60 million
5/8/2025Q1 2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.23$1.72+$0.49-$0.63$574.15 million$599.49 million
4/24/2025Q1 2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.75$0.86+$0.11$0.49$352.57 million$355.35 million
4/9/2025Q3 2025
Neogen Corporation stock logo
NEOG
Neogen
$0.12$0.10-$0.02-$0.05$225.27 million$221.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Haemonetics Corporation stock logo
HAE
Haemonetics
1.12
1.62
0.99
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.75
2.59
1.52
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.51
4.87
3.26
Neogen Corporation stock logo
NEOG
Neogen
0.33
3.91
2.45

Institutional Ownership

CompanyInstitutional Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%
Neogen Corporation stock logo
NEOG
Neogen
96.73%

Insider Ownership

CompanyInsider Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
1.84%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
1.50%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.70%
Neogen Corporation stock logo
NEOG
Neogen
1.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,02348.04 million47.16 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
15,00024.61 million24.24 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,40059.10 million56.91 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.04 million214.59 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Haemonetics stock logo

Haemonetics NYSE:HAE

$72.15 +1.07 (+1.51%)
Closing price 06/23/2025 03:59 PM Eastern
Extended Trading
$72.10 -0.05 (-0.07%)
As of 06/23/2025 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$128.07 +0.33 (+0.26%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$128.06 -0.01 (-0.01%)
As of 06/23/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$92.32 +0.34 (+0.37%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$92.31 -0.01 (-0.01%)
As of 06/23/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Neogen stock logo

Neogen NASDAQ:NEOG

$4.77 -0.17 (-3.44%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$4.82 +0.06 (+1.15%)
As of 06/23/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.